Shennon Biotechnologies Inc. — Form D
Shennon Biotechnologies Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-03-16. The offering totals $7.3M, of which $7.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-03-16
- Form: D
- Accession: 0001961082-23-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.3M
- Amount sold: $7.3M
- Investors: 9
- Date of first sale: 2022-12-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-476105
Issuer
- Name: Shennon Biotechnologies Inc.
- CIK: 0001961082
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 953 INDIANA STREET, SAN FRANCISCO, CA, 94107
- Phone: 000-000-0000
Officers, directors & promoters (3)
| Name | Role | Location |
|---|
| James Hardiman | Director | SOUTH SAN FRANCISCO, CA |
| LI SUN | Director | SAN FRANCISCO, CA |
| LI SUN | Executive Officer | SAN FRANCISCO, CA |
More